These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. da Silva Junior IA; Stone SC; Rossetti RM; Jancar S; Lepique AP J Immunol Res; 2017; 2017():5482768. PubMed ID: 29445756 [TBL] [Abstract][Full Text] [Related]
29. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro]. Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285 [TBL] [Abstract][Full Text] [Related]
30. Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor. Wang Y; Gao Z; Zhang Y; Feng SQ; Liu Y; Shields LBE; Zhao YZ; Zhu Q; Gozal D; Shields CB; Cai J Mol Neurobiol; 2016 Jul; 53(5):3448-3461. PubMed ID: 26084439 [TBL] [Abstract][Full Text] [Related]
31. Sirtuin 1 Mediates the Actions of Peroxisome Proliferator-Activated Receptor δ on the Oxidized Low-Density Lipoprotein-Triggered Migration and Proliferation of Vascular Smooth Muscle Cells. Hwang JS; Ham SA; Yoo T; Lee WJ; Paek KS; Lee CH; Seo HG Mol Pharmacol; 2016 Nov; 90(5):522-529. PubMed ID: 27573670 [TBL] [Abstract][Full Text] [Related]
32. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis. Kim J; Jang SW; Park E; Oh M; Park S; Ko J J Mol Cell Cardiol; 2014 Jul; 72():157-67. PubMed ID: 24650873 [TBL] [Abstract][Full Text] [Related]
33. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer. Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638 [TBL] [Abstract][Full Text] [Related]
36. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Shindou H; Ishii S; Uozumi N; Shimizu T Biochem Biophys Res Commun; 2000 May; 271(3):812-7. PubMed ID: 10814544 [TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700 [TBL] [Abstract][Full Text] [Related]
38. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Guerrero AT; Zarpelon AC; Vieira SM; Pinto LG; Ferreira SH; Cunha FQ; Verri WA; Cunha TM Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):51-9. PubMed ID: 23187752 [TBL] [Abstract][Full Text] [Related]
39. Molecular basis for the activation of PAF receptor by PAF. Fan W; Xu Y; He X; Luo P; Zhu J; Li J; Wang R; Yuan Q; Wu K; Hu W; Zhao Y; Xu S; Cheng X; Wang Y; Xu HE; Zhuang Y Cell Rep; 2024 Jul; 43(7):114422. PubMed ID: 38943642 [TBL] [Abstract][Full Text] [Related]
40. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor. Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]